Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 23 hours agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 8 hours agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 1 day agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 1 day agoModerna said the European Union is planning to buy up to 36 million doses of its Covid vaccine each...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 1 day agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 1 day agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 1 day agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 day agoI am very pleased with this partnership as it is the very first time that Moderna works with the Brazilian government and we look forward to providing...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 1 day agoManagement expects...and end 2024 with a cash balance of around $9 billion. Recent Updates The...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 22 hours agoThe Spikevax story is over, but... Barring a renewed Covid surge -- fingers crossed! -- there isn't much future in Spikevax. Yet as ever, Moderna...
